why choose us

First received: October 11, 2023

Clinical Trial: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gram-Negative Bacterial Infections

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Single-arm, Open-label Study to Assess the Pharmacokinetics, Safety, and Tolerability of Cefiderocol in Hospitalized Pediatric Patients From Birth to < 3 Months of Age With Suspected

Brief Summary: The primary purpose of this study is to understand the pharmacokinetics (PK) of single and multiple doses of cefiderocol in children from birth to less than 3 months of age with suspected or confirmed aerobic Gram-negative bacterial infections.

Read more